Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Microbiome in Pediatric Rheumatic Diseases

Matthew Stoll, MD, PhD  |  Issue: April 2016  |  April 15, 2016

TABLE 1: Comparison of the findings in the fecal microbiota in patients from Florence, Italy, and Nanoro, Burkina Faso.

(click for larger image) Table 1: Comparison of the findings in the fecal microbiota in patients from Florence, Italy, and Nanoro, Burkina Faso.

Source: Data adapted from De Filippo et al.7

Or would it? As discussed above, the most likely microbial beneficiary of a diet that resulted in loss of Prevotella would be Bacteroides. Bacteroides fragilis is thought to have anti-inflammatory effects through its polysaccharide A tail.11 However, both rat and mouse models of HLA-B27-associated spondyloarthritis are abrogated in the germ-free state, and in both, the disease comes right back with addition of Bacteroides species.12,13 Further, as noted above, two studies in geographically distinct areas have both identified elevated Bacteroides genus in children with JIA.2,5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Finally, it bears mentioning that P. copri is neither necessary nor sufficient for RA; in the same study by Scher et al, subjects with long-standing RA had similar abundance of P. copri as healthy controls.9 A more recent study of newly diagnosed RA patients conducted in China did not show alterations in the abundance of this organism at diagnosis.14 Thus, the impact of the relative abundance of Prevotella and Bacteroides in the gut microbiota on rheumatic diseases remains unclear.

This is not to indicate that there is no such thing as harmful bacteria. Clearly, such pathogens as Salmonella typhimurium, E. coli 0157:J7, Shigella flexneri and Clostridium difficile are generally less than ideal organisms to dominate one’s microbiota, regardless of their association with inflammatory disease. Conversely, one species, Faecalibacterium prausnitzii, has repeatedly been shown to be deficient in IBD, as well as in ERA/JIA in one study, and is thought to have anti-inflammatory properties in vitro and, likely, in vivo as well.2,4,15 Interestingly, in the Burkina Faso study, the single most common genus in the Florence population was Faecalibacterium, indicating that their population of microbiota may not have been entirely bad.7 It’s possible that with the exception of cases of reactive arthritis triggered by intestinal pathogens such as Salmonella and Shigella, no single organism is either necessary or sufficient for causing most cases of rheumatic disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Diversity Matters

Figure 1: Clustering of gut microbial bacteria into two distinct enterotypes. Subjects in green represent enterotype 1, which is dominated by Bacteroides; subjects in red represent enterotype 2, which is dominated by Prevotella.10

(click for larger image) Figure 1: Clustering of gut microbial bacteria into two distinct enterotypes. Subjects in green represent enterotype 1, which is dominated by Bacteroides; subjects in red represent enterotype 2, which is dominated by Prevotella.10

An alternative possibility is that the significance of the intestinal microbiota may be in the form of its overall community structure. Think of it as a team sport; having a full lineup and a deep bench is surely more useful than a single big-name player. The microbial counterpart to a deep bench is high alpha diversity, which is a measure of the richness, as well as the evenness, of the organisms present in a community. Specifically, richness speaks to the number of different organisms, while evenness speaks to their distribution (see Figure 2).

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsPediatric ConditionsResearch Rheum Tagged with:gastrointestinal diseasejuvenile rheumatoid arthritisMicrobiomemicrobiotiaPediatricResearchRheumatic Disease

Related Articles

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    Links Between Gut Bacteria and Rheumatoid Arthritis

    March 19, 2019

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting, Allen C. Steere, MD, delivered the Rheumatology Research Foundation Memorial Lecture honoring the late Charles M. Plotz, MD: Linking Gut Microbial Immunity with Autoimmunity in Joints in Patients with Rheumatoid Arthritis. Dr. Steere is professor of medicine at Harvard Medical School, Boston, and director of translational research in rheumatology…

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    2014 ACR/ARHP Annual Meeting: Microbiota Power

    March 1, 2015

    Gut bacteria may hold clues to breakthrough rheumatic disease treatments

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences